LML Payment Systems Stock Soars (LMLP)

NEW YORK ( TheStreet) -- Shares of LML Payment Systems (Nasdaq: LMLP) have taken a tremendous swing upward. The stock is trading at $2.71 as of 1:01 p.m. ET, 23.7% above Monday's closing price of $2.19. Volume is at 280,246, 0.8 times the daily average of 357,300.

LML Payment Systems has a market cap of $63.1 million and is part of the services sector and diversified services industry. Shares are down 37.2% year to date as of the close of trading on Monday.

LML Payment Systems Inc. provides electronic payment, risk management, and authentication services primarily to businesses and organizations using the Internet to receive or send payments in Canada and the United States. The company has a P/E ratio of 21, below the average diversified services industry P/E ratio of 33 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates LML Payment Systems as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full LML Payment Systems Ratings Report.

See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center.

Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting SOAR to 95370 or select from multiple alert options.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing